Otezla
RxNorm concept 1492733, brand name (bn).
- RxCUI
- 1492733
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1492733 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- apremilast 10 MG [Otezla] (SBDC, ingredient of)
- apremilast Oral Tablet [Otezla] (SBDF, ingredient of)
- Otezla Oral Product (SBDG, ingredient of)
- Otezla Pill (SBDG, ingredient of)
- apremilast 10 MG Oral Tablet [Otezla] (SBD, ingredient of)
- apremilast 20 MG [Otezla] (SBDC, ingredient of)
- apremilast 20 MG Oral Tablet [Otezla] (SBD, ingredient of)
- apremilast 30 MG [Otezla] (SBDC, ingredient of)
- apremilast 30 MG Oral Tablet [Otezla] (SBD, ingredient of)
- apremilast 75 MG [Otezla] (SBDC, ingredient of)
- apremilast Extended Release Oral Tablet [Otezla] (SBDF, ingredient of)
- 24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla] (SBD, ingredient of)
- apremilast (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1492733 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1492733 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1492733. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.